Market LIVE
Published markets; coverage varies by country
Product profile · United States

CHEWTADZY

 ·  Patent Litigation & Settlement History ↓

IngredientTADALAFIL
Application typeNDA
Application218527
Product003
Dosage formTABLET, CHEWABLE
RouteORAL
Strength20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval date2024-06-28
Marketing statusDiscontinued
Status event—
ApplicantB BETTER
Product source

Current GenericRadar decision

Year2024
SelectionDISQUALIFIED
ReviewFINAL
Anchor typeFDA_MARKETING_STATUS
Anchor date—
Patent anchor2018-05-21
Exclusivity anchor2008-11-21
Protection date2018-05-21
First Final ANDA—
Status event—

FDA_DISCONTINUED_EVENT_YEAR

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
US58590062018-05-21HISTORICAL_REFERENCE_SCOPE_REVIEWED —YNTRUE_DS
English description not available.
—2018-05-21—

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2003-11-212008-11-21English description not available.YY2008-11-21—Source

2026-10-13 · HISTORICAL_RECORDS_RECOVERED · Historical coverage: ANNUALS_AND_MONTHLY_REVIEWED

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (3)
TypeDateRoleBasisSource
PATENT2018-05-21CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_EXCLUSIVITY2008-11-21SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS—TERMINAL_STATUSFDA_DISCONTINUED_EVENT_YEARSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.